CA9 and neoplasm: In human renal carcinoma and cervical cancer cells, AZ and AZ-based derivatives, as single agent or in combination therapy with synthesized aromatic sulfonamides with high affinity for CAIX demonstrated antitumor activity including inhibition of cell proliferation, induction of apoptosis and suppression of tumor cell invasiveness [18, 19].